CoChat

Duloxetine in the treatment of irritable bowel syndrome: an open‐label pilot study

Brennan, Brian P., Fogarty, Kate V., Roberts, Jacqueline L., Reynolds, Karina A., Pope, Harrison G., Hudson, James I. · 2009 · Human Psychopharmacology: Clinical and Experimental
Cited by 99

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Objective: To assess the efficacy of duloxetine for irritable bowel syndrome (IBS). Methods: We conducted an open‐label 12‐week trial of duloxetine 60 mg daily in 15 patients with IBS without concurrent major depressive disorder. The primary outcome measure was average abdominal pain. Secondary measures included IBS symptoms, Clinical Global Impression‐Severity, Hamilton Anxiety Rating Scale, IBS Quality‐of‐Life Scale, and Sheehan Disability Scale. We analyzed changes using random regression and one‐sample t‐tests. Results: Fourteen patients completed at least one post‐baseline evaluation; eight completed the study. Duloxetine was associated with significant improvement (p < 0.05) in pain, severity of illness, quality of life, loose stool, work and family disability, and anxiety. However, duloxetine did not improve hard stool. Although we found no evidence of serious duloxetine toxicity, seven participants withdrew over the course of the study because of adverse drug events. Conclusions: In this small, open‐label study, duloxetine appeared to be effective for many features of IBS, but its adverse effects, most notably constipation, limited its use. Since our study excluded individuals with concurrent major depression, it appears that duloxetine may benefit IBS independently of its antidepressant effects. These encouraging but preliminary open‐label findings support further investigation of duloxetine treatment in placebo‐controlled trials of IBS. Copyright © 2009 John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hup.1038

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 99

Metadata

Authors
Brennan, B. P., Fogarty, K. V., Roberts, J. L., Reynolds, K. A., Pope, H. G., & Hudson, J. I.
Venue
Human Psychopharmacology: Clinical and Experimental
Publisher
Wiley
Published
2009-06-22
Volume
24
Issue
5
Pages
423-428
ISSN
  • 0885-6222 (ISSN-L)
  • 1099-1077
OpenAlex
W2137924300
Cited by
99
References
10
FWCI
3.09
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Duloxetine in the treatment of irritable bowel syndrome: an open‐label pilot study. https://app.cochat.ai/papers/10.1002/hup.1038
The paper
Brennan, B. P., Fogarty, K. V., Roberts, J. L., Reynolds, K. A., Pope, H. G., & Hudson, J. I. (2009). Duloxetine in the treatment of irritable bowel syndrome: an open‐label pilot study. Human Psychopharmacology: Clinical and Experimental. https://doi.org/10.1002/hup.1038

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.